| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJCARD.2003.11.065 |
| P698 | PubMed publication ID | 15019902 |
| P50 | author | Hannele Laivuori | Q41533751 |
| P2093 | author name string | Risto Kaaja | |
| Vilho Hiilesmaa | |||
| Minna Salminen | |||
| Hannu Leinonen | |||
| Leena Haukkamaa | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 805-808 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Risk for subsequent coronary artery disease after preeclampsia | |
| P478 | volume | 93 |
| Q33591844 | 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. |
| Q46567506 | Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity |
| Q47637223 | Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia |
| Q36112146 | An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women |
| Q36254426 | Birthweight of offspring and mortality of parents: the Jerusalem perinatal study cohort |
| Q38645883 | Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study |
| Q38080492 | Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis |
| Q34756489 | Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study |
| Q34235812 | Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review |
| Q89835034 | Circulating Neutrophils Do Not Predict Subclinical Coronary Artery Disease in Women with Former Preeclampsia |
| Q89391735 | Gene-Centric Analysis of Preeclampsia Identifies Maternal Association at PLEKHG1 |
| Q37413791 | Genetic polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and susceptibility to pre-eclampsia: a case-control study and a meta-analysis |
| Q34674453 | Gestational hypoxia and epigenetic programming of brain development disorders. |
| Q33400488 | Glomerular endothelium: a porous sieve and formidable barrier. |
| Q28239814 | Hypertensive disorders of pregnancy |
| Q39462044 | Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). |
| Q38707968 | Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia |
| Q45041144 | Increased plasma norepinephrine levels in previously pre-eclamptic women |
| Q90434468 | Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia |
| Q38651066 | Long-Term Effects of Pregnancy Complications on Maternal Health: A Review. |
| Q37020195 | Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists |
| Q37748773 | Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature |
| Q46913686 | Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring |
| Q37857465 | Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension |
| Q36577103 | Mechanisms of disease: Pre-eclampsia |
| Q81446389 | Pre-eclampsia |
| Q34407459 | Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life |
| Q44210067 | Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women |
| Q46336679 | Pre-eclampsia outcomes in different hemodynamic models |
| Q28200816 | Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy |
| Q37990465 | Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk |
| Q46171078 | Preeclampsia does not share common risk alleles in 9p21 with coronary artery disease and type 2 diabetes |
| Q33712654 | Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands |
| Q79144654 | Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria |
| Q57167914 | Residual Vascular Dysfunction in Women with a History of Preeclampsia |
| Q39706974 | Risk of coronary artery disease in women with history of pregnancies complicated by preeclampsia and LBW. |
| Q33479988 | Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study |
| Q40387082 | Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia. |
| Q35114857 | Synergistic effect of gestational hypertension and postpartum incident hypertension on cardiovascular health: a nationwide population study |
| Q33639463 | The Role of Statins in Prevention of Preeclampsia: A Promise for the Future? |
Search more.